Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 66993-370

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 66993-370). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Medroxyprogesterone 01)

Figure 1 (Medroxyprogesterone 01)
This text is displaying odds ratio and confidence intervals for different studies related to DMPA usage. The displayed odds ratio is on a logarithmic scale. The text shows odds ratios for different time periods of DMPA usage and indicates increased risk for DMPA usage through a ratio greater than 1.*
FDA Label Image

Chemical Structure (Medroxyprogesterone 02)

FDA Label Image

Logo (Medroxyprogesterone 03)

FDA Label Image

Image (Medroxyprogesterone 04)

Image (Medroxyprogesterone 04)
This text appears to be a list of different birth control methods available. The first part of the text is likely showing the rates of pregnancy using different methods. The methods listed include injections, intrauterine devices, sterilization, birth control pills, patches, vaginal rings, condoms, diaphragms, spermicides, and withdrawal. The final line states "No birth control."*
FDA Label Image

Logo (Medroxyprogesterone 05)

FDA Label Image

Principal Display Panel (150 mg/mL Vial Label)

Principal Display Panel (150 mg/mL Vial Label)
This is a description for MedroxyPROGESTERone Acetate Injectable Suspension, USP with a concentration of 150 mg/mL. It is meant for intramuscular use only and comes in a single-dose vial. The medication should be shaken vigorously before each use and stored upright. The NDC number for this medication is 66993-370-83 and it is distributed by Prasco Laboratories in Mason, OH. For further information, refer to the package insert.*
FDA Label Image

Principal Display Panel (150 mg/mL Vial Carton)

Principal Display Panel (150 mg/mL Vial Carton)
This is a description of a medication called Medroxyprogesterone Acetate Injectable Suspension in a 1mL single-dose vial intended for intramuscular use only. It contains 150mg of medroxyprogesterone acetate and other ingredients such as polyethylene glycol, polysorbate 80, and sodium chloride. The medication may only be prescribed by a physician and comes with accompanying prescribing information. The vials must be stored upright at controlled room temperature. The medication is distributed by Prasco Laboratories in the USA.*
FDA Label Image

Principal Display Panel (150 mg/mL Vial Carton)

Principal Display Panel (150 mg/mL Vial Carton)
This appears to be a description of a medication containing medroxyprogesterone acetate in an injectable suspension form, with instructions for dosage and use. It includes some details on the ingredients and how to properly prepare and administer the medication.*
FDA Label Image

Principal Display Panel (150 mg/mL Syringe Label)

Principal Display Panel (150 mg/mL Syringe Label)
This is a single-use syringe containing Medroxyprogesterone Acetate Injectable Suspension, a medication used for intramuscular use only. The syringe is 1 mL and contains 150 mg per mL. The medication is prescription-only and should be shaken vigorously before use. It is distributed by Prasco Laboratories in Mason, OH. The LOT/EXP number is not available.*
FDA Label Image

Principal Display Panel (150 mg/mL Syringe Carton)

Principal Display Panel (150 mg/mL Syringe Carton)
This text provides information about the dosage and use of the Medroxyprogesterone Acetate Injectable Suspension, USP 150 mg/mL. The medication should be stored at a controlled room temperature between 20° and 25°C. The medication contains medroxyprogesterone acetate and other ingredients such as polystyrene glycol, polysorbate, and sodium chloride. The pH of the suspension may be adjusted with sodium hydroxide and/ or hydrochloric acid. The medication is for intramuscular use only and the syringe should be prepared by shaking it before use, removing the protective cap, attaching the needle to the syringe barrel, removing the safety shield from the needle, and administering the dose. trademarked products mentioned are Terumo® and SurGuard®.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.